MEG3 levels were downregulated in EC tissues compared with that in adjacent non-tumor tissues, and EC patients with low MEG3 expression exhibited shorter overall survival compared with patients with high expression levels (Dong et al., 2019b). Here, MEG3 is linked to neoplasm.